- New Purchases: ASRT, FB, GM, AAP, NXPI, WDAY, MOMO,
- Added Positions: ONCE, FLIN, PBYI, ARRY, ENTA, MNTA, RARE, ALNY, FOLD, NBIX, INCY, AGIO, REGN, IRWD, UTHR, ICPT, EXEL, HALO, BMRN, VRTX, ACOR, LGND, TBPH, BIIB, HDB, EQR, IBN, CHRW, TV, IVZ, ATHM, VEDL, CTRP,
- Reduced Positions: MPC, NEE, WEC, D, XEL, PRNB, GBT, KURA, RGNX, CTMX, AIMT, ADAP, BPMC, ASND, FGEN, CRBP, SAGE, QURE, CBAY, ITCI, MYOK, VYGR, CRNX, STIM, AUTL, EIDX, KNSA, UBX, DNLI, NITE, AKCA, ATNX, BHVN, RARX, KDMN, BOLD, RETA, XNCR, GLYC, PRTA, BCRX, AMRS, CCXI, SRNE, MRTX, ABEO, IMGN, EPZM, ESPR, FPRX, XLRN, KPTI, AGEN, BLUE, OPTN, RYTM, DCPH, HPQ, INO, AVRO, APLS, ERJ, ALLK, CYTK, ABEV, ADBE, TCDA, ARWR, APTX, GTHX, KT, ATH, GX1N, RCKT, BABA, PTCT, PRQR, VKTX, FATE, JD, STML, HTHT, TGTX, YUMC, NTES, ZIOP, ACHN, BGNE, WVE, PBR.A, AKBA,
- Sold Out: MPLX, EQM, ET, EPD, MMP, PAA, ENLK, PSXP, BPMP, ANDX, WES, NBLX, OKE, WMB, PSX, GEL, NGL, NS, TGE, AM, DCP, EQGP, KMI, SHLX, CEQP, ENBL, DTE, SRE, PEG, NI, CMS, IONS, ES, RDUS, PTLA, CELG, GILD, MDCO, SGEN, VNDA, RTRX, NEP, LOXO, SRPT, DVAX, LXRX, NKTR, SJI, CLVS, HIFR, TCP, OMER, PNW, BPL, HEP, PPL, SWX, CWEN, IYR, SVRA, EXC, INSM, PGNX, SGMO, FTS, MDGL, DPOA, IOVA, MGNX, CARA, GERN, IMMU, LJPC, NRG, NVAX, DRNA, SO, ITUB, ENLC, MSFT, VVC, CI, FMX, HD, ILMN, INTC, LMT, PGR, ROP, SQM, PYPL, RLJPA.PFD, SREPA.PFD, CSX, CDNS, CAT, CX, CNC, CINF, CTXS, KO, ED, GLW, DRI, ETFC, BEN, GRMN, GGB, HIG, HSIC, HUM, JNJ, KSS, LRCX, MU, MS, NTRS, ORLY, OGE, ODFL, OMC, PCAR, PEP, PFE, PRU, PHM, O, RHI, SIVB, SPG, STT, SNPS, TTM, TMK, TSCO, WDC, EDU, DFS, TEL, LULU, RGA, LEA, TAL, HCA, WP, VOYA, CDW, VEEV, TWTR, HPE, UA,
For the details of Virtus ETF Advisers LLC's stock buys and sells, go to https://www.gurufocus.com/guru/virtus+etf+advisers+llc/current-portfolio/portfolio
These are the top 5 holdings of Virtus ETF Advisers LLC- Spark Therapeutics Inc (ONCE) - 19,751 shares, 4.79% of the total portfolio. Shares added by 29.68%
- Puma Biotechnology Inc (PBYI) - 33,378 shares, 2.76% of the total portfolio. Shares added by 27.11%
- Array BioPharma Inc (ARRY) - 48,922 shares, 2.54% of the total portfolio. Shares added by 27.14%
- Ultragenyx Pharmaceutical Inc (RARE) - 16,385 shares, 2.42% of the total portfolio. Shares added by 24.60%
- Enanta Pharmaceuticals Inc (ENTA) - 10,634 shares, 2.16% of the total portfolio. Shares added by 30.64%
Virtus ETF Advisers LLC initiated holding in Assertio Therapeutics Inc. The purchase prices were between $3.61 and $5.07, with an estimated average price of $4.29. The stock is now traded at around $4.17. The impact to a portfolio due to this purchase was 0.69%. The holding were 64,315 shares as of .
New Purchase: Facebook Inc (FB)Virtus ETF Advisers LLC initiated holding in Facebook Inc. The purchase prices were between $131.09 and $173.37, with an estimated average price of $158.51. The stock is now traded at around $180.73. The impact to a portfolio due to this purchase was 0.16%. The holding were 435 shares as of .
New Purchase: General Motors Co (GM)Virtus ETF Advisers LLC initiated holding in General Motors Co. The purchase prices were between $32.25 and $40.14, with an estimated average price of $37.94. The stock is now traded at around $37.05. The impact to a portfolio due to this purchase was 0.05%. The holding were 585 shares as of .
New Purchase: NXP Semiconductors NV (NXPI)Virtus ETF Advisers LLC initiated holding in NXP Semiconductors NV. The purchase prices were between $71.97 and $97.14, with an estimated average price of $87.6. The stock is now traded at around $98.17. The impact to a portfolio due to this purchase was 0.03%. The holding were 152 shares as of .
New Purchase: Workday Inc (WDAY)Virtus ETF Advisers LLC initiated holding in Workday Inc. The purchase prices were between $154.02 and $197.93, with an estimated average price of $181.52. The stock is now traded at around $201.28. The impact to a portfolio due to this purchase was 0.03%. The holding were 80 shares as of .
New Purchase: Advance Auto Parts Inc (AAP)Virtus ETF Advisers LLC initiated holding in Advance Auto Parts Inc. The purchase prices were between $151.77 and $170.53, with an estimated average price of $161.65. The stock is now traded at around $155.77. The impact to a portfolio due to this purchase was 0.03%. The holding were 92 shares as of .
Added: Spark Therapeutics Inc (ONCE)Virtus ETF Advisers LLC added to a holding in Spark Therapeutics Inc by 29.68%. The purchase prices were between $37.95 and $113.98, with an estimated average price of $72.19. The stock is now traded at around $109.03. The impact to a portfolio due to this purchase was 1.1%. The holding were 19,751 shares as of .
Added: Franklin FTSE India (FLIN)Virtus ETF Advisers LLC added to a holding in Franklin FTSE India by 113.61%. The purchase prices were between $21 and $23.52, with an estimated average price of $22.02. The stock is now traded at around $22.19. The impact to a portfolio due to this purchase was 0.76%. The holding were 28,491 shares as of .
Added: Puma Biotechnology Inc (PBYI)Virtus ETF Advisers LLC added to a holding in Puma Biotechnology Inc by 27.11%. The purchase prices were between $20.35 and $42.37, with an estimated average price of $30.25. The stock is now traded at around $17.55. The impact to a portfolio due to this purchase was 0.59%. The holding were 33,378 shares as of .
Added: Array BioPharma Inc (ARRY)Virtus ETF Advisers LLC added to a holding in Array BioPharma Inc by 27.14%. The purchase prices were between $14.25 and $24.45, with an estimated average price of $20.7. The stock is now traded at around $21.56. The impact to a portfolio due to this purchase was 0.54%. The holding were 48,922 shares as of .
Added: Enanta Pharmaceuticals Inc (ENTA)Virtus ETF Advisers LLC added to a holding in Enanta Pharmaceuticals Inc by 30.64%. The purchase prices were between $69.08 and $105.66, with an estimated average price of $89.42. The stock is now traded at around $87.25. The impact to a portfolio due to this purchase was 0.51%. The holding were 10,634 shares as of .
Added: Momenta Pharmaceuticals Inc (MNTA)Virtus ETF Advisers LLC added to a holding in Momenta Pharmaceuticals Inc by 30.09%. The purchase prices were between $10.47 and $15.1, with an estimated average price of $12.75. The stock is now traded at around $13.49. The impact to a portfolio due to this purchase was 0.49%. The holding were 69,315 shares as of .
Sold Out: MPLX LP (MPLX)Virtus ETF Advisers LLC sold out a holding in MPLX LP. The sale prices were between $30.3 and $35.68, with an estimated average price of $33.55.
Sold Out: EQM Midstream Partners LP (EQM)Virtus ETF Advisers LLC sold out a holding in EQM Midstream Partners LP. The sale prices were between $38.87 and $47.04, with an estimated average price of $43.75.
Sold Out: Energy Transfer LP (ET)Virtus ETF Advisers LLC sold out a holding in Energy Transfer LP. The sale prices were between $13.21 and $15.62, with an estimated average price of $14.83.
Sold Out: Enterprise Products Partners LP (EPD)Virtus ETF Advisers LLC sold out a holding in Enterprise Products Partners LP. The sale prices were between $24.59 and $29.3, with an estimated average price of $27.88.
Sold Out: Magellan Midstream Partners LP (MMP)Virtus ETF Advisers LLC sold out a holding in Magellan Midstream Partners LP. The sale prices were between $56.64 and $63.65, with an estimated average price of $60.37.
Sold Out: Plains All American Pipeline LP (PAA)Virtus ETF Advisers LLC sold out a holding in Plains All American Pipeline LP. The sale prices were between $20.04 and $24.99, with an estimated average price of $23.6.
Here is the complete portfolio of Virtus ETF Advisers LLC. Also check out:
1. Virtus ETF Advisers LLC's Undervalued Stocks
2. Virtus ETF Advisers LLC's Top Growth Companies, and
3. Virtus ETF Advisers LLC's High Yield stocks
4. Stocks that Virtus ETF Advisers LLC keeps buying
